English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduIn the first year after the sudden removal of a requirement that prescribers get special permission to prescribe medication for opioid addiction, a study finds more prescribers started providing it, but the number of patients receiving it didn’t rise very much.
Tag: Prescription
Patent expert says pending Supreme Court ruling could leave patients with fewer treatment options
As the U.S. Supreme Court considers a case involving a cholesterol lowering drug, Sean Tu, a West Virginia University College of Law professor, said he believes pharmaceutical companies manipulate the patent system to maintain monopoly rights.
New Jersey Regulation Not Associated With Curbed Opioid Prescriptions or Shortened Usage
Rutgers research shows that it is difficult to dictate physician behavior, but that may be a good thing.
Study Highlights Underuse of Medications for Alcohol Use Disorder in Acute Care Settings
New research has revealed a significant gap in prescribing of effective medications for alcohol use disorder (AUD). The study, reported in Alcoholism: Clinical and Experimental Research, showed that just one in twenty patients with an alcohol-related diagnosis were prescribed an approved AUD drug (naltrexone, disulfiram, or acamprosate). The findings reinforce and build on previous evidence of under-prescribing, despite these treatments being proven to reduce heavy drinking and relapse. In the inpatient acute care setting, provision of AUD medication has been shown to be both feasible and associated with a reduction in re-admissions and emergency department (ED) visits. However, few prior studies had reported on prescribing habits in this setting. The current study examined prescribing in the acute inpatient care setting compared to other care settings within the University of Colorado Healthcare System.